Literature DB >> 10631935

The specificity of proteasomes: impact on MHC class I processing and presentation of antigens.

G Niedermann1, E Geier, M Lucchiari-Hartz, N Hitziger, A Ramsperger, K Eichmann.   

Abstract

We have studied polypeptide processing by purified proteasomes, with regard to proteolytic specificity and cytotoxic T-lymphocyte (CTL) epitope generation. Owing to defined preferences with respect to cleavage sites and fragment length, proteasomes degrade polypeptide substrates into cohorts of overlapping oligopeptides. Many of the proteolytic fragments exhibit structural features in common with major histocompatibility complex (MHC) class I ligands including fragment size and frequencies of amino acids at fragment boundaries. Proteasomes frequently generate definitive MHC class I ligands and/or slightly longer peptides, while substantially larger peptides are rare. Individual CTL epitopes are produced in widely varying amounts, often consistent with immunohierarchies among CTL epitopes. We further found that polypeptide processing is remarkably conserved among proteasomes of eukaryotic origin and that invertebrate proteasomes can efficiently produce known high-copy MHC class I ligands, suggesting evolutionary adaptation of the transporter associated with antigen processing and MHC class I to ancient constraints imposed by proteasomal protein degradation.

Mesh:

Substances:

Year:  1999        PMID: 10631935     DOI: 10.1111/j.1600-065x.1999.tb01354.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  17 in total

1.  26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.

Authors:  P Cascio; C Hilton; A F Kisselev; K L Rock; A L Goldberg
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

2.  Class I molecules with similar peptide-binding specificities are the result of both common ancestry and convergent evolution.

Authors:  Alessandro Sette; John Sidney; Brian D Livingston; John L Dzuris; Claire Crimi; Christopher M Walker; Scott Southwood; Edward J Collins; Austin L Hughes
Journal:  Immunogenetics       Date:  2003-02-14       Impact factor: 2.846

3.  Characterization and phylogenetic analysis of a cnidarian LMP X-like cDNA.

Authors:  Larry J Dishaw; Manuel L Herrera; Charles H Bigger
Journal:  Immunogenetics       Date:  2006-03-22       Impact factor: 2.846

4.  Immunoproteasome in the blood plasma of children with acute appendicitis, and its correlation with proteasome and UCHL1 measured by SPR imaging biosensors.

Authors:  E Matuszczak; A Sankiewicz; W Debek; E Gorodkiewicz; R Milewski; A Hermanowicz
Journal:  Clin Exp Immunol       Date:  2017-10-16       Impact factor: 4.330

5.  Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta.

Authors:  S Murata; H Udono; N Tanahashi; N Hamada; K Watanabe; K Adachi; T Yamano; K Yui; N Kobayashi; M Kasahara; K Tanaka; T Chiba
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

6.  Comparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection.

Authors:  Nourredine Himoudi; Jean-Daniel Abraham; Anne Fournillier; Yu Chun Lone; Aurélie Joubert; Anne Op De Beeck; Delphine Freida; François Lemonnier; Marie Paule Kieny; Geneviève Inchauspé
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  Similar intracellular peptide profile of TAP1/β2 microglobulin double-knockout mice and C57BL/6 wild-type mice as revealed by peptidomic analysis.

Authors:  Leandro M Castro; Denise A Berti; Lilian C Russo; Verônica Coelho; Fábio C Gozzo; Vitor Oliveira; Emer S Ferro
Journal:  AAPS J       Date:  2010-07-28       Impact factor: 4.009

8.  Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1.

Authors:  W M Cohen; A Bianco; F Connan; L Camoin; M Dalod; G Lauvau; E Ferriès; B Culmann-Penciolelli; P M van Endert; J P Briand; J Choppin; J G Guillet
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.

Authors:  Karina Yusim; Can Kesmir; Brian Gaschen; Marylyn M Addo; Marcus Altfeld; Søren Brunak; Alexandre Chigaev; Vincent Detours; Bette T Korber
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Simplified synthetic TMC-95A/B analogues retain the potency of proteasome inhibitory activity.

Authors:  Zhi-Qiang Yang; Benjamin H B Kwok; Songnian Lin; Michael A Koldobskiy; Craig M Crews; Samuel J Danishefsky
Journal:  Chembiochem       Date:  2003-06-06       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.